Abstract:Objective: To evaluate the genetic contribution of ANXA11 to Chinese amyotrophic lateral sclerosis (ALS) patients with and without cognitive dementia. Background: Recently, ANXA11 gene was identified be associated with ALS patients of European ancestry. However, the pathogenicity of ANXA11 in other ALS cohorts remained unproved. Design/Methods: Sanger sequencing was used to screen all the coding exons of ANXA11 and intron-exon boundaries in 18 familial ALS (FALS), 353 unrelated sporadic ALS (SALS) and 12 amyotrophic lateral sclerosis-frontotemporal lobar dementia (ALS-FTD) patients of Chinese origin. The transcripts in peripheral blood generated from a splicing mutation was examined by reverse transcriptase PCR. Results: We identified 6 nonsynonymous heterozygous mutations (c.107C>G, p.P36R;c.119A>G, p.D40G; c.382G>A, p.V128M; c.687T>A, p.S229R; c.904C>T, p.R302C; c.1471G>A, p.G491R) and 1 splice-site mutation(c.174-2A>G, p.A58_Q187del) in 10 unrelated patients, accounting for a mutant frequency of 5.6% (1/18) in FALS, 2.3% (8/353) in SALS and 8.3% (1/12) in ALS-FTD. A novel p. P36R mutation was identified in one FALS index, one SALS patient and one ALS-FTD. Another ALS patient with documented cognitive decline carried a p.G491R mutation but was lost to follow-up. The splicing mutation (c.174-2A>G) caused in-frame skipping of the entire exon 6 and further supported the loss-of-function mechanism. Conclusions: Our result showed that ANXA11 is the most frequently mutated genes in Chinese patients with SALS. The study findings further expand the ANXA11 phenotype, firstly highlighting its pathogenic role in ALS-FTD. Study Supported by: This study was funded by the National Key Research and Development Program of China (Grant number: 2016YFC0905100), the Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (CIFMS) (Grant number: 2016-I2M-1-002; 2016-12M-1-004), the National Natural Science Foundation of China (NSFC) (Grant number: 81230015), the Beijing Municipal Science and Technology Commission (Grant number: Z151100003915078). Disclosure: Dr. Zhang has nothing to disclose. Dr. Liu has nothing to disclose. Dr. Liu has nothing to disclose. Dr. Shen has nothing to disclose. Dr. Tai has nothing to disclose. Dr. Shu has nothing to disclose. Dr. Ding has nothing to disclose. Dr. Fu has nothing to disclose. Dr. Liu has nothing to disclose. Dr. Wang has nothing to disclose. Dr. LI has nothing to disclose. Dr. Liu has nothing to disclose. Dr. Zhang has nothing to disclose. Dr. Cui has nothing to disclose.

Identification of a pathogenic mutation in ARPP21 in patients with amyotrophic lateral sclerosis

Mutation Spectrum of Chinese Patients with Familial and Sporadic Amyotrophic Lateral Sclerosis

Novel Pathogenic Variants Leading to Sporadic Amyotrophic Lateral Sclerosis in Greek Patients

Rare Variant Burden Analysis within Enhancers Identifies CAV1 as an ALS Risk Gene

Rare, Low-Frequency and Common Coding Variants of ARHGEF28 Gene and Their Association with Sporadic Amyotrophic Lateral Sclerosis.

Identify Mutation in Amyotrophic Lateral Sclerosis Cases Using HaloPlex Target Enrichment System

Exome sequencing in amyotrophic lateral sclerosis implicates a novel gene, DNAJC7, encoding a heat-shock protein

Role of Genetics in Amyotrophic Lateral Sclerosis: a Large Cohort Study in Chinese Mainland Population.

Functional identification of protocadherin alpha 9 (PCDHA9) as a candidate causative gene for amyotrophic lateral sclerosis

Genetic and in silico analysis of Indian sporadic young onset patient with amyotrophic lateral sclerosis

ANXA11 Mutations Prevail in Chinese Amyotrophic Lateral Sclerosis Patients with and Without Cognitive Dementia (P1.320)

Mapping of Gene Expression Reveals CYP27A1 as a Susceptibility Gene for Sporadic ALS

Identification of ALS5/SPG11/ KIAA1840 Mutations in Patients with Autosomal Recessive Form of Charcot-Marie-Tooth Disease Type 2 (S44.002)

Comprehensive Genetic Analysis of a Hungarian Amyotrophic Lateral Sclerosis Cohort

Concomitant presence of a novel ARPP21 variant and CNVs in Chinese familial amyotrophic lateral sclerosis-frontotemporal dementia patients

Novel and Recurrent Mutations in a Cohort of Chinese Patients with Young-Onset Amyotrophic Lateral Sclerosis

Whole-genome sequencing reveals that variants in the Interleukin 18 Receptor Accessory Protein 3′UTR protect against ALS

Sqstm1 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis

Unbiased Label-Free Quantitative Proteomics of Cells Expressing Amyotrophic Lateral Sclerosis (ALS) Mutations in CCNF Reveals Activation of the Apoptosis Pathway: A Workflow to Screen Pathogenic Gene Mutations

The impact of age on genetic testing decisions in amyotrophic lateral sclerosis

CREB3 gain of function variants protect against ALS